ProMIS Historical Cash Flow
| PMN Stock | USD 0.70 0.00 0.000001% |
Analysis of ProMIS Neurosciences cash flow over time is an excellent tool to project ProMIS Neurosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 0.0 or Total Cash From Financing Activities of 28.4 M as it is a great indicator of ProMIS Neurosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining ProMIS Neurosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ProMIS Neurosciences is a good buy for the upcoming year.
ProMIS |
About ProMIS Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ProMIS balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ProMIS's non-liquid assets can be easily converted into cash.
ProMIS Neurosciences Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from ProMIS Neurosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ProMIS Neurosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.At this time, ProMIS Neurosciences' Investments are very stable compared to the past year. As of the 28th of March 2025, Change To Operating Activities is likely to grow to about 3.3 M, though Free Cash Flow is likely to grow to (12.3 M).
ProMIS Neurosciences cash flow statement Correlations
Click cells to compare fundamentals
ProMIS Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ProMIS Neurosciences cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (496.2K) | 16.0M | (11.1M) | 8.7M | 10.0M | 10.5M | |
| Free Cash Flow | (3.5M) | (9.3M) | (17.0M) | (14.4M) | (12.9M) | (12.3M) | |
| Change In Working Capital | 688.1K | (1.6M) | 5.4M | (2.7M) | (3.1M) | (2.9M) | |
| Begin Period Cash Flow | 1.3M | 807.0K | 16.9M | 8.0M | 9.1M | 9.6M | |
| Other Cashflows From Financing Activities | 3.0M | 2.4M | 6.5B | 23.5M | 27.0M | 25.7M | |
| Depreciation | 12.3K | 45.7K | 11.2K | 21.2M | 24.3M | 25.5M | |
| Other Non Cash Items | 119.7K | 364.9K | (4.9M) | (289.6M) | (260.6M) | (247.6M) | |
| Total Cash From Operating Activities | (3.4M) | (9.3M) | (17.0M) | (14.4M) | (12.9M) | (12.3M) | |
| Net Income | (4.4M) | (9.2M) | (18.1M) | (17.5M) | (15.8M) | (15.0M) | |
| Total Cash From Financing Activities | 3.0M | 25.2M | 6.5M | 23.5M | 27.0M | 28.4M | |
| End Period Cash Flow | 806.9K | 16.8M | 5.9M | 16.7M | 19.2M | 20.2M | |
| Stock Based Compensation | 205.4K | 515.6K | 487.6K | 271.5M | 312.3M | 327.9M | |
| Investments | (3.2K) | 3.0K | (2.0K) | 43.0 | 49.45 | 51.92 | |
| Total Cashflows From Investing Activities | (208.0) | (111.9K) | 120.3K | (2.0K) | (2.3K) | (2.2K) | |
| Change To Operating Activities | 841.6K | 750.0K | (1.9M) | 2.7M | 3.1M | 3.3M | |
| Issuance Of Capital Stock | 2.1M | 20.0M | 5.0M | 23.2M | 26.7M | 28.1M | |
| Change To Netincome | 647.4K | 414.5K | 1.4M | (4.6M) | (4.2M) | (4.0M) | |
| Change To Liabilities | (171.4K) | 92.8K | (40.2K) | 2.7M | 3.1M | 3.2M |
Pair Trading with ProMIS Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with ProMIS Stock
Moving against ProMIS Stock
| 0.74 | LUCD | Lucid Diagnostics | PairCorr |
| 0.68 | WM | Waste Management | PairCorr |
| 0.57 | PG | Procter Gamble | PairCorr |
| 0.53 | GE | GE Aerospace | PairCorr |
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.